IDYA IDEAYA Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 4, 2026
$37,36
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$26,0552-Wochen-Tief
$42,6852-Wochen-Hoch
Marktkapitalisierung (MRQ)
$3.60B
P/E (TTM)
-19.6
EPS (TTM)
$-1.91
Umsatz (TTM)
$234M
Ihre Abzeichen
52W-Spanne
$26–$43
Analystenbewertung
BUY
Kursziel
$53
P/E
-19.6
ROE
-16.2%
Nettogewinnmarge
-74.8%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
IDYA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$37.36
Marktkapitalisierung (MRQ)
$3.60B
P/E (TTM)
-19.6
EPS (TTM)
$-1.91
Umsatz (TTM)
$234M
ROE (TTM)
-16.2%
52W-Spanne
$26–$43
IDYA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über IDEAYA Biosciences, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter145
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$219M2019-12-31 → 2025-12-31
EPS$-1.282020-12-31 → 2025-12-31
Freier Cashflow$-73M2019-12-31 → 2025-12-31
Nettogewinnmarge-74.8%2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | IDYA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -19.65-Jahres-Durchschnitt ≈-16.5 | ≈-16.5 | · | · | |
| P/S (TTM) | 15.45-Jahres-Durchschnitt ≈96.0 | ≈96.0 | 15.3 | Fairer Wert | |
| K/B (MRQ) | 3.05-Jahres-Durchschnitt ≈2.9 | ≈2.9 | 4.0 | Unterbewertet | |
| Kurs / FCF (TTM) | -31.65-Jahres-Durchschnitt ≈-19.0 | ≈-19.0 | · | · | |
| Kurs / Cashflow (TTM) | -32.25-Jahres-Durchschnitt ≈-19.6 | ≈-19.6 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 3.25-Jahres-Durchschnitt ≈2.9 | ≈2.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | IDYA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -92.7%5-Jahres-Durchschnitt ≈-1124.3% | ≈-1124.3% | -779.6% | Unterdurchschnittlich | |
| EBITDA-Marge (TTM) | -91.5%5-Jahres-Durchschnitt ≈-1113.0% | ≈-1113.0% | -779.6% | Unterdurchschnittlich | |
| Nettogewinnmarge (TTM) | -74.8%5-Jahres-Durchschnitt ≈-949.9% | ≈-949.9% | -162.8% | Schwach | |
| ROA (TTM) | -14.9%5-Jahres-Durchschnitt ≈-18.6% | ≈-18.6% | -17.4% | Spitzenklasse | |
| ROE (TTM) | -16.2%5-Jahres-Durchschnitt ≈-17.7% | ≈-17.7% | -29.1% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | IDYA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 10.55-Jahres-Durchschnitt ≈12.6 | ≈12.6 | 9.0 | Starke Liquidität | |
| Quick Ratio | 10.95-Jahres-Durchschnitt ≈12.4 | ≈12.4 | 6.8 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | IDYA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 3024.4%5-Jahres-Durchschnitt ≈605.1% | ≈605.1% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 62.5%5-Jahres-Durchschnitt ≈10.6% | ≈10.6% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 62.1% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | IDYA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.25-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.3 | Unterdurchschnittlich | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.5M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
49.0%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 3, 2026 | $-1.22 | $-1.11 | -9.5% |
| 31. März 2026 | $-1.11 | $-1.01 | -10.0% | |
| 31. Dezember 2025 | $-0.94 | $-0.99 | 4.8% | |
| 30. September 2025 | $1.33 | $-0.56 | 339.3% | |
| 30. Juni 2025 | $-0.88 | $-0.81 | -9.3% | |
| 31. März 2025 | $-0.82 | $-0.67 | -21.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $219M | $7M | $23M | $51M | $28M | $20M | $0 | |
| R&D Expense | $315M | $295M | $130M | $90M | $58M | $40M | $34M | |
| SG&A Expense | $63M | $39M | $28M | $24M | $20M | $15M | $10M | |
| Operating Expenses | $378M | $334M | $158M | $113M | $78M | $55M | $44M | |
| Operating Income | $-159M | $-327M | $-134M | $-63M | $-50M | $-35M | $-44M | |
| Interest Income | · | · | · | · | · | · | $2M | |
| Other Non-op | $46M | $52M | $21M | $4M | $506.0K | $849.0K | $2M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-114M | $-274M | $-113M | $-59M | $-50M | $-34M | $-42M | |
| EPS (Basic) | $-1.28 | $-3.36 | $-1.96 | $-1.42 | $-1.41 | $-1.40 | · | |
| EPS (Diluted) | $-1.28 | $-3.36 | $-1.96 | $-1.42 | $-1.41 | $-1.40 | · | |
| Shares (Basic) | 88,485,238 | 81,678,069 | 57,519,929 | 41,444,696 | 35,252,443 | 24,721,775 | · | |
| Shares (Diluted) | 88,485,238 | 81,678,069 | 57,519,929 | 41,444,696 | 35,252,443 | 24,721,775 | · | |
| EBITDA | $-157M | $-325M | $-132M | $-60M | $-49M | $-34M | $-43M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $113M | $84M | $157M | $69M | $92M | $72M | $34M | |
| Short-term Investments | $527M | $592M | $368M | $296M | $155M | $212M | $65M | |
| Receivables | · | $3.0K | $18.0K | $211.0K | $1M | $2M | · | |
| Prepaid Expense | $21M | $13M | $8M | $5M | $3M | $3M | $3M | |
| Current Assets | $667M | $690M | $533M | $370M | $251M | $289M | $102M | |
| PP&E (Net) | $8M | $9M | $6M | $7M | $5M | $4M | $5M | |
| PP&E (Gross) | $22M | $21M | $16M | $14M | $10M | $8M | $7M | |
| Accum. Depreciation | $14M | $12M | $10M | $8M | $6M | $4M | $3M | |
| Other Non-current Assets | · | · | $25.0K | $99.0K | $291.0K | $82.0K | $16.0K | |
| Total Assets | $1.11B | $1.12B | $649M | $388M | $381M | $298M | $113M | |
| Accounts Payable | $18M | $15M | $7M | $4M | $2M | $953.0K | $709.0K | |
| Accrued Liabilities | $41M | $30M | $19M | $17M | $12M | $9M | $5M | |
| Current Liabilities | $59M | $46M | $27M | $32M | $45M | $39M | $7M | |
| Capital Leases | $28M | $19M | $1M | $2M | $3M | $5M | $6M | |
| Other Non-current Liabilities | · | · | · | · | · | $12.0K | $34.0K | |
| Total Liabilities | $86M | $65M | $28M | $39M | $80M | $100M | $13M | |
| Common Stock | $9.0K | $9.0K | $7.0K | $5.0K | $4.0K | $3.0K | $2.0K | |
| Retained Earnings | $-737M | $-623M | $-348M | $-235M | $-177M | $-127M | $-92M | |
| AOCI | $2M | $812.0K | $562.0K | $-3M | $-712.0K | $7.0K | $65.0K | |
| Stockholders' Equity | $1.02B | $1.06B | $621M | $349M | $302M | $198M | $100M | |
| Liabilities + Equity | $1.11B | $1.12B | $649M | $388M | $381M | $298M | $113M | |
| Shares Outstanding | 87,796,561 | 86,503,509 | 65,039,369 | 48,193,179 | 38,533,045 | 29,537,216 | 20,339,461 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Stock-based Comp | $46M | $35M | $18M | $12M | $8M | $4M | $2M | |
| Other Non-cash | $-6M | $-10M | $-23M | $-42M | $-16M | $85M | $-751.0K | |
| Operating Cash Flow | $-71M | $-248M | $-115M | $-87M | $-56M | $55M | $-39M | |
| CapEx | $2M | $4M | $2M | $3M | $3M | $493.0K | $1M | |
| Investing Cash Flow | $70M | $-503M | $-158M | $-33M | $-70M | $-146M | $2M | |
| Stock Issued | $0 | $274M | $281M | $86M | $86M | $101M | $50M | |
| Net Stock Activity | $0 | $274M | $281M | $86M | $86M | $101M | · | |
| Financing Cash Flow | $30M | $678M | $363M | $97M | $145M | $129M | $51M | |
| Net Change in Cash | $29M | $-73M | $89M | $-23M | $20M | $38M | $14M | |
| Taxes Paid | · | · | $0 | $0 | $4.0K | $1.0K | $1.0K | |
| Free Cash Flow | $-73M | $-251M | $-118M | $-91M | $-58M | $55M | $-41M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -72.8% | -4671.1% | -574.9% | -122.7% | -179.9% | -180.9% | · | |
| Net Margin | -52.0% | -3921.1% | -483.0% | -115.2% | -178.1% | -176.6% | · | |
| EBITDA Margin | -71.6% | -4637.0% | -564.3% | -118.6% | -173.7% | -173.8% | · | |
| ROA | -10.2% | -30.9% | -21.8% | -15.2% | -14.6% | -16.8% | -40.1% | |
| ROE | -11.5% | -24.5% | -20.0% | -16.3% | -16.1% | -17.5% | -39.8% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.3 | 15.0 | 19.7 | 11.7 | 5.6 | 7.5 | 14.6 | |
| Quick Ratio | 10.9 | 14.7 | 19.4 | 11.5 | 5.5 | 7.4 | 14.3 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | 666.7 | 204.2 | 77.5 | 18.8 | 20.8 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $11.65 | $12.24 | $9.55 | $7.25 | $7.82 | $6.71 | $4.94 | |
| Revenue / Share | $2.47 | $0.09 | $0.41 | $1.23 | · | · | · | |
| Cash Flow / Share | $-0.80 | $-3.03 | $-2.00 | $-2.10 | · | · | · | |
| Cash / Share | $1.29 | $0.98 | $2.41 | $1.42 | $2.39 | $2.44 | $1.67 | |
| EPS (TTM) | $-1.28 | $-3.36 | $-1.96 | $-1.42 | $-1.41 | $-1.40 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3024.4% | -70.1% | -54.1% | 82.3% | 43.0% | · | · | |
| Revenue CAGR 3Y | 62.5% | -37.0% | 6.2% | · | · | · | · | |
| Revenue CAGR 5Y | 62.1% | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $219M | $7M | $23M | $51M | $28M | $20M | $0 | |
| Net Income TTM | $-114M | $-274M | $-113M | $-59M | $-50M | $-34M | $-42M | |
| Market Cap | $3.04B | $2.22B | $2.31B | $876M | $911M | $414M | $153M | |
| P/E | -27.0 | -7.6 | -18.2 | -12.8 | -16.8 | -10.0 | · | |
| P/S | 13.9 | 317.6 | 99.0 | 17.2 | 32.6 | 21.2 | · | |
| P/B | 3.0 | 2.1 | 3.7 | 2.5 | 3.0 | 2.1 | 1.5 | |
| P / Tangible Book | 3.0 | 2.1 | 3.7 | 2.5 | 3.0 | 2.1 | · | |
| P / Cash Flow | -42.7 | -9.0 | -20.1 | -10.0 | -16.3 | 7.5 | -3.9 | |
| P / FCF | -41.3 | -8.8 | -19.7 | -9.7 | -15.6 | 7.5 | -3.8 | |
| Earnings Yield | -3.7% | -13.1% | -5.5% | -7.8% | -6.0% | -10.0% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $7M | $11M | $208M | · | · | $7M | · | $0 | $0 | $4M | $8M | $4M | $8M | $4M | $30M | |
| R&D Expense | $109M | $96M | $87M | $83M | $74M | $71M | $140M | $57M | $55M | $43M | $39M | $34M | $29M | $28M | $25M | $22M | |
| SG&A Expense | $22M | $19M | $19M | $16M | $15M | $14M | $11M | $10M | $10M | $8M | $7M | $8M | $7M | $6M | $6M | $7M | |
| Operating Expenses | $131M | $115M | $105M | $99M | $89M | $84M | $151M | $67M | $65M | $51M | $46M | $42M | $36M | $34M | $30M | $29M | |
| Operating Income | $-122M | $-109M | $-95M | $108M | $-89M | $-84M | $-144M | $-67M | $-65M | $-51M | $-42M | $-34M | $-33M | $-26M | $-26M | $660.0K | |
| Other Non-op | $10M | $10M | $11M | $11M | $11M | $12M | $14M | $15M | $12M | $11M | $8M | $6M | $5M | $3M | $2M | $955.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-112M | $-99M | $-83M | $119M | $-77M | $-72M | $-130M | $-52M | $-53M | $-40M | $-34M | $-27M | $-28M | $-24M | $-24M | $2M | |
| EPS (Basic) | $-1.22 | $-1.11 | $-0.93 | $1.35 | $-0.88 | $-0.82 | $-1.55 | $-0.60 | $-0.68 | $-0.53 | $-0.51 | $-0.46 | $-0.50 | $-0.49 | $-0.53 | $0.04 | |
| EPS (Diluted) | $-1.22 | $-1.11 | $-0.91 | $1.33 | $-0.88 | $-0.82 | $-1.55 | $-0.60 | $-0.68 | $-0.53 | $-0.51 | $-0.46 | $-0.50 | $-0.49 | $-0.53 | $0.04 | |
| Shares (Basic) | 92,061,452 | 88,699,754 | · | 88,526,781 | 88,472,197 | 88,356,335 | · | 86,188,510 | 77,962,730 | 75,108,484 | · | 59,999,449 | 56,251,130 | 48,370,074 | · | 40,301,568 | |
| Shares (Diluted) | 92,061,452 | 88,699,754 | · | 89,690,878 | 88,472,197 | 88,356,335 | · | 86,188,510 | 77,962,730 | 75,108,484 | · | 59,999,449 | 56,251,130 | 48,370,074 | · | 41,109,571 | |
| EBITDA | $-122M | $-108M | · | $108M | $-89M | $-84M | · | $-67M | $-65M | · | · | $-34M | $-33M | $-26M | · | $660.0K |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $273M | $158M | $113M | $299M | $115M | $130M | $84M | $400M | $183M | $108M | $157M | $152M | $103M | $67M | $69M | $102M | |
| Short-term Investments | $556M | $514M | $527M | $488M | $555M | $563M | $592M | $520M | $519M | $590M | · | $317M | $391M | $272M | · | $284M | |
| Receivables | · | · | · | · | · | · | · | $20.0K | $1.0K | $15.0K | · | $7M | $160.0K | $468.0K | · | $3M | |
| Prepaid Expense | $20M | $18M | $21M | $16M | $16M | $15M | $13M | $12M | $12M | $11M | · | $7M | $8M | $4M | · | $4M | |
| Current Assets | $864M | $696M | $667M | $803M | $686M | $708M | $690M | $932M | $713M | $709M | · | $482M | $502M | $344M | · | $393M | |
| PP&E (Net) | $8M | $9M | $8M | $8M | $9M | $9M | $9M | $8M | $7M | $7M | · | $6M | $7M | $7M | · | $7M | |
| PP&E (Gross) | $24M | $24M | $22M | $22M | $22M | $21M | $21M | $19M | $18M | $17M | · | $15M | $15M | $15M | · | $14M | |
| Accum. Depreciation | $16M | $15M | $14M | $14M | $13M | $12M | $12M | $11M | $11M | $10M | · | $9M | $8M | $8M | · | $7M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | $75.0K | $92.0K | · | $105.0K | $108.0K | $114.0K | · | $146.0K | |
| Total Assets | $1.31B | $1.03B | $1.11B | $1.19B | $1.04B | $1.10B | $1.12B | $1.24B | $974M | $962M | · | $533M | $528M | $365M | · | $411M | |
| Accounts Payable | $31M | $21M | $18M | $18M | $17M | $18M | $15M | $13M | $16M | $6M | · | $5M | $6M | $4M | · | $4M | |
| Accrued Liabilities | $51M | $44M | $41M | $45M | $38M | $33M | $30M | $28M | $24M | $18M | · | $16M | $15M | $17M | · | $17M | |
| Current Liabilities | $83M | $65M | $59M | $65M | $55M | $51M | $46M | $41M | $41M | $25M | · | $25M | $25M | $30M | · | $33M | |
| Capital Leases | $28M | $28M | $28M | $27M | $26M | $26M | $19M | $19M | $1M | $1M | · | · | $611.0K | $1M | · | $2M | |
| Total Liabilities | $111M | $93M | $86M | $93M | $82M | $77M | $65M | $59M | $42M | $26M | · | $25M | $26M | $31M | · | $42M | |
| Common Stock | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $7.0K | · | $6.0K | $6.0K | $5.0K | · | $5.0K | |
| Retained Earnings | $-948M | $-835M | $-737M | $-653M | $-773M | $-695M | $-623M | $-493M | $-441M | $-388M | · | $-314M | $-287M | $-259M | · | $-211M | |
| AOCI | $-2M | $-494.0K | $2M | $2M | $2M | $2M | $812.0K | $4M | $-1M | $-923.0K | · | $-750.0K | $-1M | $-1M | · | $-4M | |
| Stockholders' Equity | $1.20B | $937M | $1.02B | $1.09B | $960M | $1.02B | $1.06B | $1.18B | $932M | $935M | $621M | $508M | $502M | $334M | $349M | $369M | |
| Liabilities + Equity | $1.31B | $1.03B | $1.11B | $1.19B | $1.04B | $1.10B | $1.12B | $1.24B | $974M | $962M | · | $533M | $528M | $365M | · | $411M | |
| Shares Outstanding | 96,375,637 | 87,856,154 | 87,796,561 | 87,666,408 | 87,641,776 | 87,565,252 | 86,503,509 | 86,357,856 | 76,090,834 | 74,764,628 | · | 58,626,437 | 57,440,328 | 48,390,394 | · | 48,090,358 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $688.0K | $688.0K | $721.0K | $661.0K | $718.0K | $600.0K | $572.0K | $577.0K | $622.0K | $616.0K | $629.0K | $640.0K | $619.0K | $588.0K | $558.0K | $569.0K | |
| Stock-based Comp | $17M | $15M | $12M | $12M | $12M | $10M | $9M | $9M | $10M | $6M | $5M | $5M | $5M | $4M | $3M | $3M | |
| Other Non-cash | · | $8M | · | · | · | $999.0K | · | · | · | · | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-88M | $-75M | $-90M | $142M | $-62M | $-60M | $-122M | $-49M | $-33M | $-44M | $-24M | $-30M | $-33M | $-28M | $-23M | $-24M | |
| CapEx | $866.0K | $967.0K | $333.0K | $42.0K | $663.0K | $1M | $1M | $457.0K | $973.0K | $1M | $838.0K | $603.0K | $884.0K | $43.0K | $0 | $1M | |
| Investing Cash Flow | $-156M | $119M | $-98M | $42M | $46M | $80M | $-197M | $-20M | $69M | $-354M | $-112M | $51M | $-121M | $24M | $-10M | $-19M | |
| Stock Issued | · | · | · | · | · | · | $-340.0K | $275M | $-344M | $344M | $128M | $-249.0K | $151M | $3M | $-375.0K | $86M | |
| Financing Cash Flow | $359M | $1M | $2M | $301.0K | $1M | $26M | $3M | $287M | $39M | $349M | $141M | $28M | $191M | $3M | $324.0K | $96M | |
| Net Change in Cash | $115M | $45M | $-186M | $184M | $-15M | $46M | $-316M | $217M | $75M | $-49M | $5M | $49M | $36M | $-1M | $-33M | $53M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Free Cash Flow | · | $-76M | · | · | · | $-62M | · | · | · | · | · | · | · | $-28M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1380.7% | -1654.6% | · | 52.2% | · | · | · | · | · | · | · | -417.1% | -922.9% | -333.5% | · | 2.2% | |
| Net Margin | -1269.6% | -1502.1% | · | 57.4% | · | · | · | · | · | · | · | -341.4% | -788.0% | -300.0% | · | 5.4% | |
| EBITDA Margin | -1380.7% | -1644.2% | · | 52.2% | · | · | · | · | · | · | · | -417.1% | -922.9% | -326.0% | · | 2.2% | |
| ROA | -9.6% | -9.2% | · | 9.8% | -7.7% | -7.0% | · | -5.9% | -7.0% | · | · | -5.8% | -6.5% | -6.5% | · | 0.40% | |
| ROE | -10.4% | -10.1% | · | 10.5% | -8.2% | -7.4% | · | -6.1% | -7.4% | · | · | -6.3% | -7.2% | -7.6% | · | 0.47% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 10.7 | · | 12.4 | 12.4 | 13.9 | · | 22.9 | 17.5 | · | · | 19.4 | 19.8 | 11.5 | · | 12.0 | |
| Quick Ratio | 10.0 | 10.4 | · | 12.2 | 12.1 | 13.6 | · | 22.6 | 17.2 | · | · | 19.1 | 19.5 | 11.4 | · | 11.9 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.2 | · | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | · | · | 1.6 | 15.8 | 13.5 | · | 13.3 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.44 | $10.67 | · | $12.46 | $10.95 | $11.70 | · | $13.67 | $12.24 | · | · | $8.67 | $8.73 | $6.90 | · | $7.67 | |
| Revenue / Share | $0.10 | $0.07 | · | $2.32 | · | · | · | $0.00 | $0.00 | · | · | $0.13 | $0.06 | $0.16 | · | $0.72 | |
| Cash Flow / Share | · | $-0.85 | · | · | · | $-0.68 | · | · | · | · | · | · | · | $-0.58 | · | · | |
| Cash / Share | $2.83 | $1.79 | · | $3.41 | $1.31 | $1.48 | · | $4.64 | $2.41 | · | · | $2.59 | $1.79 | $1.39 | · | $2.12 | |
| EPS (TTM) | $-1.91 | $-1.57 | · | $-1.92 | $-3.85 | $-3.65 | · | $-2.32 | $-2.18 | $-1.98 | · | $-1.98 | $-1.48 | $-1.55 | · | $-1.38 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $234M | · | · | · | · | · | · | $12M | $12M | $19M | · | $23M | $45M | $47M | · | $50M | |
| Net Income TTM | $-175M | $-140M | · | $-161M | $-332M | $-307M | · | $-178M | $-154M | $-119M | · | $-103M | $-74M | $-68M | · | $-53M | |
| Market Cap | $3.59B | $2.93B | · | $2.39B | $1.84B | $1.43B | · | $2.74B | $2.67B | · | · | $1.58B | $1.35B | $664M | · | $718M | |
| P/E | -19.5 | -21.2 | · | -14.2 | -5.5 | -4.5 | · | -13.7 | -16.1 | -22.2 | · | -13.6 | -15.9 | -8.9 | · | -10.8 | |
| P/S | 15.3 | · | · | · | · | · | · | 228.7 | 223.4 | · | · | 67.4 | 29.9 | 14.0 | · | 14.4 | |
| P/B | 3.0 | 3.1 | · | 2.2 | 1.9 | 1.4 | · | 2.3 | 2.9 | · | · | 3.1 | 2.7 | 2.0 | · | 1.9 | |
| P / Tangible Book | 3.0 | 3.1 | · | 2.2 | 1.9 | 1.4 | · | 2.3 | 2.9 | 3.5 | · | 3.1 | 2.7 | 2.0 | · | 1.9 | |
| P / Cash Flow | · | -38.9 | · | · | · | -23.8 | · | · | · | · | · | · | · | -23.9 | · | · | |
| Earnings Yield | -5.1% | -4.7% | · | -7.1% | -18.3% | -22.3% | · | -7.3% | -6.2% | -4.5% | · | -7.3% | -6.3% | -11.3% | · | -9.2% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $219M | $7M | $23M | $51M | $28M |
| Betriebsgewinnmarge % | -72.8% | -4671.1% | -574.9% | -122.7% | -179.9% |
| Nettoergebnis | $-114M | $-274M | $-113M | $-59M | $-50M |
| Verwässerte EPS | $-1.28 | $-3.36 | $-1.96 | $-1.42 | $-1.41 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 11.3 | 15.0 | 19.7 | 11.7 | 5.6 |
| Quick Ratio | 10.9 | 14.7 | 19.4 | 11.5 | 5.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-73M | $-251M | $-118M | $-91M | $-58M |
Institutionelle Eigentümer (13F) 308 Einreicher · $3.9B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
308
Gehaltener Wert
$3.9B
Neue Positionen
66
Geschlossene Positionen
33
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 66 (+10 vs. Vorquartal) | 33 (+4 vs. Vorquartal) | 90 (+3 vs. Vorquartal) | 91 (+15 vs. Vorquartal) | -2.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $525.858.476 | 14.109.431 | 13,64% | Aktien |
| BlackRock, Inc. | $331.451.800 | 8.893.260 | 8,60% | Aktien |
| JANUS HENDERSON GROUP PLC | $242.023.014 | 7.265.253 | 6,28% | Aktien |
| Capital Research Global Investors | $199.197.006 | 5.344.701 | 5,17% | Aktien |
| BAKER BROS. ADVISORS LP | $186.723.818 | 5.010.030 | 4,84% | Aktien |
| VANGUARD GROUP INC | $173.518.031 | 5.019.324 | 4,50% | Aktien |
| STATE STREET CORP | $169.537.913 | 4.548.911 | 4,40% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $154.023.716 | 4.132.646 | 4,00% | Aktien |
| Logos Global Management LP | $111.810.000 | 3.000.000 | 2,90% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $101.202.623 | 2.715.391 | 2,63% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $101.169.527 | 2.714.503 | 2,62% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $90.418.771 | 2.425.602 | 2,35% | Aktien |
| MORGAN STANLEY | $71.986.727 | 1.931.491 | 1,87% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $61.910.774 | 1.661.281 | 1,61% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $54.229.000 | 1.627.521 | 1,41% | Aktien |
| Fiera Capital Corp | $53.888.134 | 1.445.885 | 1,40% | Aktien |
| FEDERATED HERMES, INC. | $53.356.850 | 1.431.630 | 1,38% | Aktien |
| GSK plc | $49.693.321 | 1.333.333 | 1,29% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $47.328.764 | 1.269.889 | 1,23% | Aktien |
| GOLDMAN SACHS GROUP INC | $45.902.254 | 1.231.614 | 1,19% | Aktien |
| Candriam S.C.A. | $40.670.890 | 1.092.301 | 1,06% | Aktien |
| BANK OF AMERICA CORP /DE/ | $38.244.349 | 1.026.143 | 0,99% | Aktien |
| Sofinnova Investments, Inc. | $34.479.185 | 925.119 | 0,89% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $33.230.230 | 891.608 | 0,86% | Aktien |
| Fisher Asset Management, LLC | $31.728.173 | 851.306 | 0,82% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $30.621.479 | 821.612 | 0,79% | Aktien |
| NORTHERN TRUST CORP | $29.969.477 | 804.118 | 0,78% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $28.134.676 | 754.888 | 0,73% | Aktien |
| Pictet Asset Management Holding SA | $26.561.360 | 712.674 | 0,69% | Aktien |
| UBS Group AG | $24.475.991 | 656.721 | 0,63% | Aktien |
| Nuveen, LLC | $23.862.378 | 640.257 | 0,62% | Aktien |
| Redmile Group, LLC | $23.860.329 | 640.202 | 0,62% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $23.145.602 | 621.025 | 0,60% | Aktien |
| Qube Research & Technologies Ltd | $22.081.469 | 592.473 | 0,57% | Aktien |
| Aberdeen Group plc | $20.906.010 | 560.934 | 0,54% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $18.709.167 | 501.990 | 0,49% | Aktien |
| DAFNA Capital Management LLC | $18.532.135 | 497.240 | 0,48% | Aktien |
| Sio Capital Management, LLC | $17.903.874 | 480.383 | 0,46% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $16.771.500 | 450.000 | 0,44% | Aktien |
| Iron Triangle Partners LP | $16.160.922 | 467.484 | 0,42% | Aktien |
| Affinity Asset Advisors, LLC | $14.908.000 | 400.000 | 0,39% | Aktien |
| Walleye Capital LLC | $14.393.040 | 386.183 | 0,37% | Aktien |
| RTW INVESTMENTS, LP | $13.803.690 | 370.370 | 0,36% | Aktien |
| Rhenman & Partners Asset Management AB | $12.813.426 | 343.800 | 0,33% | Aktien |
| BIT Capital GmbH | $11.603.381 | 311.333 | 0,30% | Aktien |
| GENERAL AMERICAN INVESTORS CO INC | $11.488.105 | 308.240 | 0,30% | Aktien |
| FIRST TRUST ADVISORS LP | $11.431.789 | 306.729 | 0,30% | Aktien |
| CITADEL ADVISORS LLC | $11.197.324 | 300.438 | 0,29% | Aktien |
| WELLS FARGO & COMPANY/MN | $11.100.795 | 297.848 | 0,29% | Aktien |
| Balyasny Asset Management L.P. | $11.090.248 | 297.565 | 0,29% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Partners IV, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Dr. John D. Diekman, Andrew J. Schwab, Dr. Scott M. Rocklage ×4 Einreichungen | 11. August 2021 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 23 Insider · 13 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Yujiro S Hata | President and CEO | 30. Januar 2026 A | 690.695 | 0 | 0 | $0 |
| Joshua Bleharski | Chief Financial Officer | 30. Januar 2026 A | · | 0 | 0 | $0 |
| Paul A. Stone | Chief Financial Officer | 29. August 2023 S | 9.303 | 0 | 0 | $0 |
| Briseno Andres Ruiz | Chief Accounting Officer | 7. Juli 2026 M | 26.466 | 0 | 1 | $-382.096 |
| Stuart Dorman | Chief Commercial Officer | 30. Januar 2026 A | · | 0 | 0 | $0 |
| Michael Anthony White | Chief Scientific Officer | 30. Januar 2026 A | 0 | 0 | 0 | $0 |
| Douglas B. Snyder | SVP, General Counsel | 30. Januar 2026 A | 2.080 | 0 | 0 | $0 |
| Darrin Beaupre | Chief Medical Officer | 30. Januar 2026 A | · | 0 | 0 | $0 |
| Jason Throne | Chief Legal Officer | 27. Juni 2024 M | 63.484 | 0 | 0 | $0 |
| Dillon Michael P. | SVP, Chief Scientific Officer | 4. Oktober 2021 M | 78.789 | 0 | 0 | $0 |
| Mark Lackner | SVP, Head of Biology | 24. Februar 2021 A | 0 | 0 | 0 | $0 |
| Julie Hambleton | SVP, Chief Medical Officer | 21. Februar 2020 A | · | 0 | 0 | $0 |
| Jeffrey Hager | SVP, Chief Technology Officer | 26. Juli 2019 M | 127.853 | 0 | 0 | $0 |
| Malcolm Garret Hampton | Direktor | 16. Juni 2026 A | · | 0 | 0 | $0 |
| Scott W Morrison | Direktor | 16. Juni 2026 A | · | 0 | 0 | $0 |
| Catherine J Mackey | Direktor | 16. Juni 2026 A | · | 0 | 0 | $0 |
| Jeffrey Stein | Direktor | 16. Juni 2026 A | 54.281 | 1 | 0 | $1.648.000 |
| Terry J Rosen | Direktor | 16. Juni 2026 A | · | 0 | 0 | $0 |
| Wendy L Yarno | Direktor | 16. Juni 2026 A | · | 0 | 0 | $0 |
| Susan L. Kelley | Direktor | 31. Mai 2024 A | · | 0 | 0 | $0 |
| Timothy M Shannon | Direktor | 7. Juni 2023 A | 2.660.713 | 0 | 0 | $0 |
| John D. Diekman | Direktor | 24. September 2019 A | 118.521 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | 10%-Eigentümer | 28. Mai 2019 C | 432.384 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 44 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IDNA · iShares Trust | 3,03% | 206.476 SH | 11. September 2026 | Täglich |
| BBC · ETFis Series Trust I | 0,82% | 10.725 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,56% | 78.418 NS | 31. Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,54% | 36.625 SH | 1. Oktober 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,38% | 138.610 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,24% | 6.817 SH | 1. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,23% | 634.181 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,18% | 66.106 SH | 19. August 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,16% | 1.071 NS | 31. Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 24.851 NS | 31. Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,12% | 3.052 NS | 31. Juli 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,12% | 46.812 NS | 31. Juli 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,12% | 84.714 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,10% | 2.133.932 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,10% | 40.157 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 482.551 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,09% | 62.723 SH | 1. Oktober 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 12.555 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,07% | 17.720 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,07% | 284.304 NS | 31. Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,07% | 49.180 SH | 11. September 2026 | Täglich |
| TECB · iShares Trust | 0,06% | 8.173 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 37.935 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1.071.101 SH | 19. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 19.707 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,04% | 237.675 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,03% | 4.919 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 77.245 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 8.869 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,02% | 2.603 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 14.739 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 195.984 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 6.004 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 4.381 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 21.144 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 118.619 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 25.449 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 22.336 SH | 10. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.965.870 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.704 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 709.208 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 4.115 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 7.713 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 9.505 SH | 1. September 2026 | Täglich |
IDYA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 22 Analysten
KAUF
Median-Ziel
$54.00
+44,5%
7 31,8%
Starker Kauf
13 59,1%
Kauf
2 9,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
12 Analysten · 2026-10-01Mittelwert-Ziel $52.75 +41,2%
Jetzt
Aktueller Preis $37.36
Tief$31.00
Mittelwert$52.75
Hoch$65.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
| VKTX | $4.04B | -11.0 | · | · | -47.3% | · |
| LEGN | · | -26.8 | · | · | -29.1% | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| PBLS | · | · | · | · | · | · |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 4, 2026